These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 17091486

  • 41. Extraocular retinoblastoma: a 13-year experience.
    Antoneli CB, Steinhorst F, de Cássia Braga Ribeiro K, Novaes PE, Chojniak MM, Arias V, de Camargo B.
    Cancer; 2003 Sep 15; 98(6):1292-8. PubMed ID: 12973854
    [Abstract] [Full Text] [Related]

  • 42. Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
    Koga Y, Matsuzaki A, Suminoe A, Hatano M, Saito Y, Kinoshita Y, Tajiri T, Taguchi T, Kohashi K, Oda Y, Tsuneyoshi M, Hara T.
    Pediatr Blood Cancer; 2009 Jul 15; 52(7):888-90. PubMed ID: 19260106
    [Abstract] [Full Text] [Related]

  • 43. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
    Paulino AC, Nguyen TX, Mai WY, Teh BS, Wen BC.
    Pediatr Blood Cancer; 2007 Aug 15; 49(2):145-8. PubMed ID: 16732580
    [Abstract] [Full Text] [Related]

  • 44. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.
    Raney RB, Stoner JA, Walterhouse DO, Andrassy RJ, Donaldson SS, Laurie F, Meyer WH, Qualman SJ, Crist WM, Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.
    Pediatr Blood Cancer; 2004 Jun 15; 42(7):618-25. PubMed ID: 15127417
    [Abstract] [Full Text] [Related]

  • 45. The Intergroup Rhabdomyosarcoma Study-II.
    Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J.
    Cancer; 1993 Mar 01; 71(5):1904-22. PubMed ID: 8448756
    [Abstract] [Full Text] [Related]

  • 46. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL, Anderson JR, Crist WM, Breneman JC, Wharam MD, Wiener ES, Qualman SJ, Donaldson SS.
    J Clin Oncol; 1999 Nov 01; 17(11):3468-75. PubMed ID: 10550144
    [Abstract] [Full Text] [Related]

  • 47. The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
    Malempati S, Weigel BJ, Chi YY, Tian J, Anderson JR, Parham DM, Teot LA, Rodeberg DA, Yock TI, Shulkin BL, Spunt SL, Meyer WH, Hawkins DS.
    Cancer; 2019 Jan 15; 125(2):290-297. PubMed ID: 30351457
    [Abstract] [Full Text] [Related]

  • 48. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
    Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J, Shamberger RC, Goorin A, Miser J, Meyer J, Arndt CA, Sailer S, Marcus K, Perlman E, Dickman P, Grier HE.
    J Clin Oncol; 2009 May 20; 27(15):2536-41. PubMed ID: 19349548
    [Abstract] [Full Text] [Related]

  • 49. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
    Oberlin O, Rey A, Sanchez de Toledo J, Martelli H, Jenney ME, Scopinaro M, Bergeron C, Merks JH, Bouvet N, Ellershaw C, Kelsey A, Spooner D, Stevens MC.
    J Clin Oncol; 2012 Jul 10; 30(20):2457-65. PubMed ID: 22665534
    [Abstract] [Full Text] [Related]

  • 50. Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.
    Koumarianou AA, Xiros N, Papageorgiou E, Pectasides D, Economopoulos T.
    Anticancer Res; 2007 Jul 10; 27(2):1191-7. PubMed ID: 17465262
    [Abstract] [Full Text] [Related]

  • 51. Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
    Winter S, Fasola S, Brisse H, Mosseri V, Orbach D.
    Pediatr Blood Cancer; 2015 Nov 10; 62(11):1935-41. PubMed ID: 26150380
    [Abstract] [Full Text] [Related]

  • 52. Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease.
    Bergeron C, Thiesse P, Rey A, Orbach D, Boutard P, Thomas C, Schmitt C, Scopinaro MJ, Bernard F, Stevens M, Oberlin O.
    Eur J Cancer; 2008 Feb 10; 44(3):427-31. PubMed ID: 18215514
    [Abstract] [Full Text] [Related]

  • 53. Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.
    Kojima Y, Hashimoto K, Ando M, Yonemori K, Yamamoto H, Kodaira M, Yunokawa M, Shimizu C, Tamura K, Hosono A, Makimoto A, Fujiwara Y.
    Cancer Chemother Pharmacol; 2012 Sep 10; 70(3):391-7. PubMed ID: 22806306
    [Abstract] [Full Text] [Related]

  • 54. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
    Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, Marsden HB, Martelli H, Sanchez de Toledo J, Spicer RD, Spooner D, Terrier-Lacombe MJ, van Unnik A, Oberlin O.
    J Clin Oncol; 2005 Apr 20; 23(12):2618-28. PubMed ID: 15728225
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Rhabdomyosarcoma of the ear and temporal bone.
    Wiatrak BJ, Pensak ML.
    Laryngoscope; 1989 Nov 20; 99(11):1188-92. PubMed ID: 2811561
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Role of surgery for nonmetastatic abdominal rhabdomyosarcomas: a report from the Italian and German Soft Tissue Cooperative Groups Studies.
    Cecchetto G, Bisogno G, Treuner J, Ferrari A, Mattke A, Casanova M, Dall'Igna P, Zanetti I, Volpato S, Siracusa F, Scarzello G, Boglino C, Carli M, Italian and German Soft Tissue Cooperative Groups Studies.
    Cancer; 2003 Apr 15; 97(8):1974-80. PubMed ID: 12673726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.